MetaVia (MTVA) vs Theriva Biologics (TOVX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Theriva Biologics is the larger company by market cap ($10.4 million vs $8.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | MTVA | TOVX |
|---|---|---|
| Share price | $1.34 | $0.2271 |
| Market cap | $8.83M | $10.42M |
| 1-day change | -8.22% | -2.95% |
| YTD return | — | +11.43% |
| 1-year return | — | -55.00% |
| 5-year return | — | -99.78% |
| P/E ratio (TTM) | — | 0.31 |
| EPS (TTM) | $-3.65 | $0.73 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.85 | $0.86 |
| 52-week low | $0.966 | $0.16 |
| Distance from 52-week high | -90.98% | -73.59% |
| Average volume | 230.88K | 530.02K |
| Shares outstanding | 6.59M | 45.89M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
MTVA vs TOVX FAQ
Which is bigger, MetaVia or Theriva Biologics?
Theriva Biologics (TOVX) is larger, with a market capitalization of $10.42M compared with $8.83M for MetaVia (MTVA).
Are MetaVia and Theriva Biologics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.